Stimuli-responsive self-assembled polymer nanoparticles for the oral delivery of antibodies
MK Miller, FA Chapa-Villarreal, HF Oldenkamp… - Journal of Controlled …, 2023 - Elsevier
Currently, commercially available antibody therapies must be delivered via parenteral
administration. Oral delivery of antibodies could increase patient compliance and improve …
administration. Oral delivery of antibodies could increase patient compliance and improve …
Stimuli-responsive self-assembled polymer nanoparticles for the oral delivery of antibodies
MK Miller, FA Chapa-Villarreal… - Journal of controlled … - pubmed.ncbi.nlm.nih.gov
Currently, commercially available antibody therapies must be delivered via parenteral
administration. Oral delivery of antibodies could increase patient compliance and improve …
administration. Oral delivery of antibodies could increase patient compliance and improve …
Stimuli-responsive self-assembled polymer nanoparticles for the oral delivery of antibodies
MK Miller, FA Chapa-Villarreal… - … Clinics and Research, 2023 - journals.lww.com
Currently, commercially available antibody therapies must be delivered via parenteral
administration. Oral delivery of antibodies could increase patient compliance and improve …
administration. Oral delivery of antibodies could increase patient compliance and improve …